Redbiotec AG(製薬・医療分野):企業M&A動向

◆英語タイトル:Redbiotec AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH322395D
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月30日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

Redbiotec AG (Redbiotec) is a biopharmaceutical company. It focuses on the development of prophylactic vaccines that target various virus-associated diseases. The company employs its proprietary rePAX co-expression technology for producing multi-component virus-like particles (VLPs) and other protein assemblies. The pipeline products of Redbiotec find applications in the areas of congenital CMV infection caused by human cytomegalovirus (HCMV); cervical cancer induced by human papilloma virus (HPV) and influenza. It also develops Herpes vaccines that target Epstein-Barr and Varicella Zoster viruses. The company works in collaborations with various pharmaceutical and biotech companies and universities. It is a spin-off of ETH Zurich. Redbiotec is headquartered in Schlieren, Switzerland.

Redbiotec AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Redbiotec AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Redbiotec Secures Financing 10
Redbiotec Secures First Round Of Venture Financing 11
Partnerships 12
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 12
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 13
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 14
Redbiotec Extends Drug Discovery Agreement With Merck 15
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 16
Redbiotec Enters Into Drug Discovery Agreement With Merck 17
Redbiotec Enters Into An Agreement With Roche 18
Redbiotec AG – Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Redbiotec AG, Pharmaceuticals & Healthcare, Key Facts 1
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Redbiotec AG, Deals By Therapy Area, 2009 to YTD 2015 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Redbiotec Secures Financing 10
Redbiotec Secures First Round Of Venture Financing 11
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 12
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 13
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 14
Redbiotec Extends Drug Discovery Agreement With Merck 15
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 16
Redbiotec Enters Into Drug Discovery Agreement With Merck 17
Redbiotec Enters Into An Agreement With Roche 18
Redbiotec AG, Key Competitors 19
Redbiotec AG, Key Employees 20

List of Figures
Redbiotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Redbiotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★調査レポート[Redbiotec AG(製薬・医療分野):企業M&A動向] (コード:GDPH322395D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Redbiotec AG(製薬・医療分野):企業M&A動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆